These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8768721)

  • 1. Effects of metrifonate, its transformation product dichlorvos, and other organophosphorus and reference cholinesterase inhibitors on Morris water escape behavior in young-adult rats.
    van der Staay FJ; Hinz VC; Schmidt BH
    J Pharmacol Exp Ther; 1996 Aug; 278(2):697-708. PubMed ID: 8768721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metrifonate induces cholinesterase inhibition exclusively via slow release of dichlorvos.
    Hinz VC; Grewig S; Schmidt BH
    Neurochem Res; 1996 Mar; 21(3):331-7. PubMed ID: 9139239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of long-term behavioral effects after sub-chronic administration of low doses of methamidophos in male and female rats.
    Temerowski M; van der Staay FJ
    Neurotoxicol Teratol; 2005; 27(2):279-97. PubMed ID: 15734279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metrifonate and dichlorvos: effects of a single oral administration on cholinesterase activity in rat brain and blood.
    Hinz V; Grewig S; Schmidt BH
    Neurochem Res; 1996 Mar; 21(3):339-45. PubMed ID: 9139240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the cholinesterase inhibitors donepezil and metrifonate on scopolamine-induced impairments in the spatial cone field orientation task in rats.
    van der Staay FJ; Bouger PC
    Behav Brain Res; 2005 Jan; 156(1):1-10. PubMed ID: 15474645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metrifonate treatment enhances acquisition of eyeblink conditioning in aging rabbits.
    Kronforst-Collins MA; Moriearty PL; Ralph M; Becker RE; Schmidt B; Thompson LT; Disterhoft JF
    Pharmacol Biochem Behav; 1997 Jan; 56(1):103-10. PubMed ID: 8981616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acute and repeated administration of a cholinesterase inhibitor on timing behaviour.
    Bouger PC; Spowart-Manning L; Ferrara A; Schmidt BH; van der Staay FJ
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):285-94. PubMed ID: 15163438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by metrifonate and dichlorvos of cholinesterases in schistosomes.
    Bueding E; Liu CL; Rogers SH
    Br J Pharmacol; 1972 Nov; 46(3):480-7. PubMed ID: 4656609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial discrimination deficits by excitotoxic lesions in the Morris water escape task.
    Spowart-Manning L; van der Staay FJ
    Behav Brain Res; 2005 Jan; 156(2):269-76. PubMed ID: 15582113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential profiles of cholinesterase inhibition and neurobehavioral effects in rats exposed to fenamiphos or profenofos.
    McDaniel KL; Moser VC
    Neurotoxicol Teratol; 2004; 26(3):407-15. PubMed ID: 15113602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal patch delivery of acetylcholinesterase inhibitors.
    Moriearty PL; Thornton SL; Becker RE
    Methods Find Exp Clin Pharmacol; 1993; 15(6):407-12. PubMed ID: 8231460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical pharmacology of metrifonate.
    Jann MW
    Pharmacotherapy; 1998; 18(2 Pt 2):55-67; discussion 79-82. PubMed ID: 9543466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An acetylcholinesterase-independent mechanism for neurobehavioral impairments after chronic low level exposure to dichlorvos in rats.
    Verma SK; Kumar V; Gill KD
    Pharmacol Biochem Behav; 2009 Mar; 92(1):173-81. PubMed ID: 19101586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of metrifonate on escape and avoidance learning in young and aged rats.
    van Der Staay FJ; Hinz VC; Schmidt BH
    Behav Pharmacol; 1996 Jan; 7(1):56-64. PubMed ID: 11224394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of subchronic administration of metrifonate on cholinergic neurotransmission in rats.
    Hinz VC; Kolb J; Schmidt BH
    Neurochem Res; 1998 Jul; 23(7):931-8. PubMed ID: 9690734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metrifonate. Summary of toxicological and pharmacological information available.
    Holmstedt B; Nordgren I; Sandoz M; Sundwall A
    Arch Toxicol; 1978 Oct; 41(1):3-29. PubMed ID: 363095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of metrifonate, a cholinesterase inhibitor, on local cerebral glucose utilization in young and aged rats.
    Bassant MH; Jazat-Poindessous F; Lamour Y
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):1014-25. PubMed ID: 8784247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acute and chronic cholinesterase inhibition on biogenic amines in rat brain.
    Soininen H; Unni L; Shillcutt S
    Neurochem Res; 1990 Dec; 15(12):1185-90. PubMed ID: 1711162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metrifonate improves working but not reference memory performance in a spatial cone field task.
    Prickaerts J; Honig W; Schmidt BH; Blokland A
    Eur J Pharmacol; 1999 Sep; 380(2-3):61-5. PubMed ID: 10513563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of metrifonate in humans.
    Unni LK; Womack C; Hannant ME; Becker RE
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):285-9. PubMed ID: 8051989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.